NEW YORK (Reuters Health) – In recent-onset active rheumatoid arthritis (RA), regular medication adjustments based on disease-activity scores (DAS) improves clinical outcomes and possibly radiological outcomes as well,…
NEW YORK (Reuters Health) – Patients with angina and multivessel coronary artery disease face poor long-term outcomes with medical management, according to a report in the December issue…
NEW YORK (Reuters Health) – An American Urological Association guideline — that heme-positive dipstick tests in asymptomatic patients be confirmed microscopically before urology referral – is often ignored,…
NEW YORK (Reuters Health) – Liver enzyme elevations occur in up to a third of patients with inflammatory arthritis who take methotrexate, leflunomide, or both, a cohort study…
NEW YORK (Reuters Health) – Not only do high-dose statins more effectively prevent first cardiovascular events compared to moderate doses, the higher doses are also better at preventing…
NEW YORK (Reuters Health) – A low platelet count in the presence of hepatitis C viremia indicates the need to begin interferon-based treatment, regardless of the degree of…
NEW YORK (Reuters Health) – Stent-assisted coiling of intracranial aneurysms significantly reduces angiographic recurrence, new research shows. But using stents also increases the risk of permanent neurologic complications…
NEW YORK (Reuters Health) – Despite leading guidelines that suggest clopidogrel be given for 12 months after placement of a drug-eluting stent (DES), patients treated for 6 months…
NEW YORK (Reuters Health) – A single 6-mL intra-articular injection of hylan G-F 20 (Synvisc-One, Genzyme Biosurgery) safely reduces knee osteoarthritis pain for 26 weeks, results of a…
NEW YORK (Reuters Health) – More than a third of patients undergoing routine outpatient endoscopic procedures are at high risk for obstructive sleep apnea (OSA), according to findings…